• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Healthcare Law's Impact on Businesses Varies

Article

Companies specializing in driving down spending on health care, whether through electronic records, preventive care or consolidating services, are turning out to be the biggest winners from the 2010 health care law.

Investors, analysts and policymakers say any business that can help health care providers cut costs or keep patients from being readmitted to the hospital soon after an in-patient visit is attracting more customers and seeing more investment.

Read the full story: http://usat.ly/PZgqBu

Source: USA Today

Related Videos
Nihar Desai, MD, MPH
Leigh Maria Ramos-Platt, MD
Dr Xin Hu
Douglas Flora, MD, FACCC
Molly Dean, MSW, Siftwell
Dr Xin Hu
Dr Xin Hu
Douglas Flora, MD, FACCC
Molly Dean, MSW, Siftwell
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Related Content
Patients with multiple myeloma who did not complete a distress screener were also less likely to receive autologous stem cell transplants. | Image credit: LIghtfieldStudios - stock.adobe.com

Disparities in Multiple Myeloma Distress Screenings May Point to Care Gaps

March 20th 2025
Article

Patients who did not complete a distress screener were also less likely to receive autologous stem cell transplants.

Read More

managed care cast logo

Varied Access: The Pharmacogenetic Testing Coverage Divide

February 18th 2025
Podcast

On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.

Listen

Orca-T is manufactured with highly purified regulatory T cells, hematopoietic stem cells, and conventional T cells from peripheral blood from matched donors. | Image credit: fotogurmespb - stock.adobe.com.jpg

Orca-T Immunotherapy Improves cGVHD-Free Survival in ALL, AML, MDS

March 20th 2025
Article

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who received standard allogeneic stem cell transplant for hematologic malignancies.

Read More

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

February 11th 2025
Podcast

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.

Listen

Doctor works on laptop | Image Credit: © lordn - stock.adobe.com

Neurologists Share Tips for Securing Patient Access to Gene Therapies

March 19th 2025
Article

Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.

Read More

A recent move by the Trump administration cancelled $400 million in funding, a lot of which was crucial for ongoing scientific and medical research. | image credit: lexiconimages - stock.adobe.com

Trump Administration Cancels Crucial Funding for Diabetes Prevention Program

March 18th 2025
Article

Recent cuts to federal grants are set to have a widespread impact across numerous scientific and medical studies.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.